Article metrics
PDF
Other content recommended for you
- The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation
- ‘A sword of Damocles’: patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study
- Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy
- Primary prevention of neurological illness early in life
- A step forward, but still inadequate: Australian health professionals’ views on the genetics and life insurance moratorium
- Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries
- Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)
- The complexities of predictive genetic testing
- Autosomal dominant polycystic kidney disease
- Genetic testing in motor neuron disease and frontotemporal dementia: a 5-year multicentre evaluation